IQuity, Diatherix Form Strategic Partnership | GenomeWeb

NEW YORK (GenomeWeb) – Diagnostics developer IQuity Labs announced today that it has a deal under which its autoimmune disease diagnostics will be made available through Diatherix's CLIA-certified clinical laboratory.

IQuity said it will introduce its first diagnostic — a test for multiple sclerosis — in mid-2016 with additional tests for other autoimmune diseases launching over the coming 12 months.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.